• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Surveillance of the Patients with High Risk of Hepatocellular Cancer.

作者信息

Örmeci Necati

机构信息

Department of Gastroenterology, Ankara University Medical School, Ankara, Turkey.

出版信息

J Gastrointest Cancer. 2017 Sep;48(3):246-249. doi: 10.1007/s12029-017-9972-3.

DOI:10.1007/s12029-017-9972-3
PMID:28634670
Abstract
摘要

相似文献

1
Surveillance of the Patients with High Risk of Hepatocellular Cancer.肝细胞癌高危患者的监测
J Gastrointest Cancer. 2017 Sep;48(3):246-249. doi: 10.1007/s12029-017-9972-3.
2
Surveillance for hepatocellular carcinoma.肝细胞癌监测
Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):783-93. doi: 10.1016/j.bpg.2014.08.008. Epub 2014 Aug 23.
3
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.肝细胞癌的流行病学：监测和诊断的目标人群。
Abdom Radiol (NY). 2018 Jan;43(1):13-25. doi: 10.1007/s00261-017-1209-1.
4
Hepatocellular carcinoma.肝细胞癌
Curr Opin Gastroenterol. 2006 May;22(3):248-53. doi: 10.1097/01.mog.0000218961.86182.8c.
5
Assessment of the Surveillance Interval at 1 Year after Curative Treatment in Hepatocellular Carcinoma: Risk Stratification.根治性治疗后 1 年的监测间隔评估：风险分层。
Gut Liver. 2018 Sep 15;12(5):571-582. doi: 10.5009/gnl17365.
6
Screening and surveillance for hepatocellular carcinoma: perspective of a new era?肝细胞癌的筛查与监测：新时代的视角？
Expert Rev Anticancer Ther. 2016 Dec;16(12):1291-1302. doi: 10.1080/14737140.2016.1246965. Epub 2016 Oct 24.
7
Surveillance for hepatocellular carcinoma.肝细胞癌监测
Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):1001-1010. doi: 10.1016/j.bpg.2016.10.006. Epub 2016 Oct 21.
8
Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience).对肝硬化患者进行肝细胞癌的半年期和年度监测：对癌症分期和患者生存的影响（意大利经验）
Am J Gastroenterol. 2002 Mar;97(3):734-44. doi: 10.1111/j.1572-0241.2002.05557.x.
9
Noncontrast magnetic resonance imaging versus ultrasonography for hepatocellular carcinoma surveillance (MIRACLE-HCC): study protocol for a prospective randomized trial.非对比磁共振成像与超声检查用于肝细胞癌监测的比较（MIRACLE-HCC）：一项前瞻性随机试验的研究方案。
BMC Cancer. 2018 Sep 24;18(1):915. doi: 10.1186/s12885-018-4827-2.
10
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol.超声造影每半年 1 次与非增强磁共振成像每年 1 次作为肝硬化患者肝癌监测工具的比较（MAGNUS-HCC）：研究方案。
BMC Cancer. 2017 Dec 21;17(1):877. doi: 10.1186/s12885-017-3819-y.

引用本文的文献

1
Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease.肝细胞癌的病因：特别关注脂肪性肝病
Front Oncol. 2020 Nov 30;10:601710. doi: 10.3389/fonc.2020.601710. eCollection 2020.

本文引用的文献

1
Hepatocellular carcinoma: a review.肝细胞癌：综述
J Hepatocell Carcinoma. 2016 Oct 5;3:41-53. doi: 10.2147/JHC.S61146. eCollection 2016.
2
Hepatocellular carcinoma screening and surveillance in 2293 chronic hepatitis B patients in an endemic area.某流行地区2293例慢性乙型肝炎患者的肝细胞癌筛查与监测
World J Gastroenterol. 2016 Sep 14;22(34):7806-12. doi: 10.3748/wjg.v22.i34.7806.
3
Advances in Management of Hepatocellular Carcinoma.肝细胞癌管理的进展
Asian Pac J Cancer Prev. 2016;17(8):3697-703.
4
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.基于证据的肝细胞癌患者诊断、分期和治疗。
Gastroenterology. 2016 Apr;150(4):835-53. doi: 10.1053/j.gastro.2015.12.041. Epub 2016 Jan 12.
5
Albumin-to-alkaline phosphatase ratio: a novel prognostic index for hepatocellular carcinoma.白蛋白与碱性磷酸酶比值：一种用于肝细胞癌的新型预后指标。
Dis Markers. 2015;2015:564057. doi: 10.1155/2015/564057. Epub 2015 Feb 9.
6
Risk prediction of hepatocellular carcinoma in patients with cirrhosis: the ADRESS-HCC risk model.肝硬化患者肝细胞癌风险预测：ADRESS-HCC 风险模型。
Cancer. 2014 Nov 15;120(22):3485-93. doi: 10.1002/cncr.28832. Epub 2014 Jul 16.
7
Screening for hepatocellular carcinoma in chronic liver disease: a systematic review.筛查慢性肝病患者的肝细胞癌：系统评价。
Ann Intern Med. 2014 Aug 19;161(4):261-9. doi: 10.7326/M14-0558.
8
Liver stiffness-based model for prediction of hepatocellular carcinoma in chronic hepatitis B virus infection: comparison with histological fibrosis.基于肝脏硬度的慢性乙型肝炎病毒感染患者肝细胞癌预测模型：与组织学纤维化的比较
Liver Int. 2015 Mar;35(3):1054-62. doi: 10.1111/liv.12621. Epub 2014 Jul 8.
9
A new laboratory-based algorithm to predict development of hepatocellular carcinoma in patients with hepatitis C and cirrhosis.一种新的基于实验室的算法，用于预测丙型肝炎和肝硬化患者发生肝细胞癌的风险。
Gastroenterology. 2014 May;146(5):1249-55.e1. doi: 10.1053/j.gastro.2014.01.045. Epub 2014 Jan 23.
10
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.基于肝硬度的慢性乙型肝炎患者肝细胞癌风险评分优化。
J Hepatol. 2014 Feb;60(2):339-45. doi: 10.1016/j.jhep.2013.09.029. Epub 2013 Oct 12.